Study of Andrographolides With or Without Capecitabine to Treat Colorectal Cancer
Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of Andrographolides
combined with Capecitabine in treatment of elderly patients with locally advanced or
recurrent or metastasis inoperable colorectal cancer